Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04453449 · ClinicalTrials.gov registry record
The Effect of Midazolam Sedation on Diagnostic Medial Branch Blocks
A clinical trial, sponsored by Henry Ford Health System.
- Completed
- Registry status
- 95
- Enrollment target
NCT04453449 is a clinical trial that has completed, run by Henry Ford Health System. The registered enrollment target is 95 participants.
The verdict
NCT04453449 has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- 95 participants
- Enrollment target
Study Summary
This prospective observational study aims to investigate the effect of midazolam sedation on the diagnostic validity of diagnostic lumbar medial branch block in patients diagnosed with lumbar spondylosis without myelopathy.
Interventions
- DRUG Midazolam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2020-06-25 |
| Est. Completion | 2021-10-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04453449
The ClinicalTrials.gov registry entry for NCT04453449 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Midazolam is the first listed.
NCT04453449 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04453449 about?
NCT04453449 is a clinical study titled "The Effect of Midazolam Sedation on Diagnostic Medial Branch Blocks". This prospective observational study aims to investigate the effect of midazolam sedation on the diagnostic validity of diagnostic lumbar medial branch block in patients diagnosed with lumbar spondylosis without myelopathy.
What is the current status of trial NCT04453449?
This trial is currently completed. The enrollment target is 95 participants. The study started on 2020-06-25. Estimated completion is 2021-10-15.
What interventions are being tested in trial NCT04453449?
The interventions under investigation include: Midazolam (DRUG).
Who is sponsoring clinical trial NCT04453449?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.